RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding (vol 43, 1, 2024)

doi:10.1186/s13046-024-02961-9

	RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding (vol 43, 1, 2024)
	Lin, Ying 1; Wu, Yun 2; Zhang, Qiangzu 3; Tu, Xunwei 1; Chen, Sufang 1; Pan, Junfan 1; Xu, Nengluan 1; Lin, Ming 1; She, Peiwei 4; Niu, Gang 3; Chen, Yusheng 1; Li, Hongru 1,5
	2024-02-02
发表期刊	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
卷号	43 期号:1 页码:1
DOI	10.1186/s13046-024-02961-9
收录类别	SCI
语种	英语
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:001284584300001
出版者	BMC
引用统计
文献类型	期刊论文
条目标识符	http://119.78.100.204/handle/2XEOYT63/39604
专题	中国科学院计算技术研究所期刊论文_英文
通讯作者	Niu, Gang; Chen, Yusheng; Li, Hongru
作者单位	1.Fujian Med Univ, Fujian Prov Hosp, Dept Resp & Crit Care Med, Shengli Clin Med Coll, Fuzhou 350001, Fujian, Peoples R China 2.Fujian Prov Hosp, Dept Gen Practice Med, Fuzhou 350001, Peoples R China 3.Chinese Acad Sci, Inst Comp Technol, High Performance Comp Res Ctr, Beijing 100095, Peoples R China 4.Fujian Prov Hosp, Ctr Expt Res Clin Med, Fuzhou 350001, Fujian, Peoples R China 5.Fujian Med Univ, Fujian Prov Hosp, Fujian Prov Key Lab Med Big Data Engn, Shengli Clin Coll, Fuzhou 350001, Fujian, Peoples R China
推荐引用方式 GB/T 7714	Lin, Ying,Wu, Yun,Zhang, Qiangzu,et al. RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding (vol 43, 1, 2024)[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2024,43(1):1.
APA	Lin, Ying.,Wu, Yun.,Zhang, Qiangzu.,Tu, Xunwei.,Chen, Sufang.,...&Li, Hongru.(2024).RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding (vol 43, 1, 2024).JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,43(1),1.
MLA	Lin, Ying,et al."RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding (vol 43, 1, 2024)".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 43.1(2024):1.